Edition:
United Kingdom

Sorrento Therapeutics Inc (SRNE.OQ)

SRNE.OQ on NASDAQ Stock Exchange Capital Market

3.00USD
7 Dec 2018
Change (% chg)

$-0.20 (-6.25%)
Prev Close
$3.20
Open
$3.22
Day's High
$3.28
Day's Low
$3.00
Volume
373,338
Avg. Vol
414,752
52-wk High
$10.65
52-wk Low
$2.15

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 4.11 -0.404
Jun '18 3.91 -0.734
Mar '18 6.25 -0.383
FY 2017 Dec '17 20.41 0.572
Sep '17 121.91 -0.027
Jun '17 4.66 -0.202
Mar '17 4.87 -0.453
FY 2016 Dec '16 4.02 -0.204
Sep '16 2.24 0.239
Jun '16 0.90 -0.931
Mar '16 0.99 -0.412
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 3 3.53 4.20 2.51 7.41
Quarter Ending Mar-19 3 7.53 10.70 4.60 11.70
Year Ending Dec-18 3 17.74 18.31 16.77 23.31
Year Ending Dec-19 3 34.62 46.57 25.06 54.90
Earnings (per share)
Quarter Ending Dec-18 3 -0.26 -0.16 -0.40 -0.21
Quarter Ending Mar-19 3 -0.22 -0.14 -0.29 -0.22
Year Ending Dec-18 3 -1.62 -1.34 -1.92 -0.90
Year Ending Dec-19 3 -0.87 -0.56 -1.16 -0.81
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 92.25 33.63
P/E High - Last 5 Yrs. -- 323.36 45.43
P/E Low - Last 5 Yrs. -- 90.29 24.43
Beta 1.68 0.91 0.90
Price to Sales (TTM) 8.72 116.41 5.77
Price to Book (MRQ) 1.49 15.60 5.12
Price to Tangible Book (MRQ) -- 14.89 6.54
Price to Cash Flow (TTM) -- 72.75 23.57
% Owned Institutions 16.91 12.59 1.83

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.49
Dividend Yield - 5 Year Avg -- 0.31 1.50
Dividend 5 Year Growth Rate -- 2.65 5.08
Payout Ratio(TTM) -- 23.68 43.75

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 417.18 358.89 7.43
Sales (TTM) vs TTM 1 Yr. Ago 264.92 90.38 5.80
Sales - 5 Yr. Growth Rate 72.80 31.32 10.19
EPS (MRQ) vs Qtr. 1 Yr. Ago 78.33 36.71 21.03
EPS (TTM) vs TTM 1 Yr. Ago 67.70 -- --
EPS - 5 Yr. Growth Rate -- 39.68 10.79
Capital Spending - 5 Yr. Growth Rate 45.51 39.59 15.12

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.98 2.28
Current Ratio (MRQ) 0.76 5.42 3.11
LT Debt to Equity (MRQ) 28.72 33.58 11.47
Total Debt to Equity (MRQ) 28.72 35.41 15.63
Interest Coverage (TTM) -39.19 -152.89 31.38

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 87.11 41.87 54.21
Gross Margin - 5 Yr. Avg. -- 49.14 51.98
EBITD Margin (TTM) -440.86 -- --
EBITD - 5 Yr. Avg -1,306.82 -506.71 11.83
Operating Margin (TTM) -396.65 -728.63 4.90
Operating Margin - 5 Yr. Avg. -1,318.88 -526.19 7.44
Pre-Tax Margin (TTM) -255.23 -694.90 5.91
Pre-Tax Margin - 5 Yr. Avg. -804.66 -531.06 7.89
Net Profit Margin (TTM) -229.98 -696.67 2.16
Net Profit Margin - 5 Yr. Avg. -996.11 -534.50 4.12
Effective Tax Rate (TTM) -- 25.12 23.36
Effective Tax Rate - 5 Yr. Avg. -- 20.63 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 102,604 25,687,363 898,926,015
Net Income/Employee (TTM) -235,968 2,194,067 106,550,787
Receivable Turnover (TTM) 9.74 18.46 5.94
Inventory Turnover (TTM) -- 2.61 3.62
Asset Turnover (TTM) 0.04 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -9.87 -1.11 11.50
Return on Assets - 5 Yr. Avg. -22.28 2.88 12.67
Return on Investment (TTM) -12.13 0.28 15.02
Return on Investment - 5 Yr. Avg. -24.93 1.84 16.45
Return on Equity (TTM) -29.69 0.94 16.60
Return on Equity - 5 Yr. Avg. -45.57 2.30 17.56
  1 Year 3 Year 5 Year
Sales % 77.60 160.69 72.80
EPS (TTM) % 2.53 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Sorrento Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.86 -0.69 99 57
13 Week -7.69 -12.19 70 62
26 Week -40.98 -45.47 29 81
52 Week -76.62 -80.19 10 47
YTD -63.27 -67.74 13 60
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 27.50%
# of Holders: 139
Total Shares Held: 33,625,474
3 Mo. Net Change: 3,624,075
# New Positions: 20
# Closed Positions: 19
# Increased Positions: 67
# Reduced Positions: 50
# Net Buyers: 17
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.